Hofseth Biocare ASA: SECOND QUARTER AND HALF YEAR 2024 FINANCIAL REPORT

HBC had gross operating income of NOK 80.4 million (76.4 million) in the second quarter and NOK 132.8 million (121.2 million) for the half year. Adjusted for asset sales in the second quarter, sales income was NOK 72.2 million (50.7 million) for the quarter, representing an increase of 42 percent compared to the same quarter in 2023.

Cash and cash equivalents increased by NOK 3.1 million during the quarter, bringing the total holding to NOK 25.3 million at the end of June, compared with NOK 22.4 million at the end of March. Including credit facilities, HBC had NOK 26.7 million in free liquidity at the end of June.